Related Experiment Video
Updated: Oct 8, 2025

09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
16.1K
Avoiding Spurious Low Platelet Counts by Redrawing Specimens with First Time Low Platelet Counts.
1Department of Pathology, Louisiana State University Health Science Center, Children's Hospital of New Orleans, New Orleans, LA, USA.
Fetal and Pediatric Pathology
|December 29, 2021
Summary
Redrawing pediatric patients with initial low platelet counts (<100 K/ml) corrected results in 62% of cases. This policy avoids unnecessary repeat testing, saving time and costs for healthcare providers.
Area of Science:
- Pediatric Hematology
- Clinical Pathology
- Hospital Quality Improvement
Background:
- Initial low platelet counts in pediatric patients often trigger repeat testing.
- The clinical significance and frequency of correction for these initial low counts are not always clear.
Purpose of the Study:
- To evaluate the effectiveness of a policy mandating redraws for pediatric patients with first-time platelet counts below 100 K/ml.
- To determine the frequency of corrected platelet counts after redraws and identify high-yield clinical areas for this policy.
Main Methods:
- A 25-month retrospective review was conducted at a children's hospital.
- Analyzed data from 99 pediatric patients who underwent automatic redraws for initial low platelet counts (<100 K/ml).
- Examined the origin of specimens and the results of repeat platelet counts.
Main Results:
- A significant 62% of redrawn specimens showed corrected platelet counts.
- Highest correction rates were observed in samples from the emergency department (74%), pediatric intensive care unit (71%), and operating room (67%).
- Lower correction rates were noted in cardiac intensive care (38%) and general hospital floors (44%).
Conclusions:
- The policy of redrawing pediatric patients with initial low platelet counts (<100 K/ml) is effective, with 62% correction rates.
- This approach successfully avoids unnecessary delays and additional costs associated with provider-ordered repeat testing.
- The findings support the continued implementation of this redrawing policy, particularly in high-acuity areas.

